Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

antineoplaston A10

A piperidinedione antineoplaston with potential antineoplastic activity. Antineoplaston A10 was originally isolated from human urine but is now synthetically derived. This agent intercalates into DNA, resulting in cell cycle arrest in G1 phase, reduction of mitosis, and decreased protein synthesis. Antineoplaston A10 may also inhibit ras-oncogene expression and activate tumor suppressor gene p53, leading to cell differentiation and apoptosis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Atengenal
Abbreviation:A10
Chemical structure:3-phenylacetylamino-2, 6-piperidinedione
benzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (S)-
IND number:43013
NSC code:619130
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search